MD MPH
Cleveland Clinic
Dr. Bukavina is an assistant professor of Urologic Oncology at Cleveland Clinic Glickman Urologic Institute, and translational science lead in GU oncology at Cleveland Clinic Lerner College of Medicine. Dr. Bukavina completed her training at Case Western Reserve School of Medicine, followed by a fellowship in urologic oncology at Fox Chase Cancer Center. In addition to her surgical training, she holds a master's degree in epidemiology from Johns Hopkins School of Medicine and a master's degree in immunology and molecular genetics from Drexel. Her educational background reflects her commitment to both surgery and cancer research.
Dr. Bukavina is a recipient of multiple grants and awards for her dedication to bladder and kidney cancer research, including the Robert Wood Johnson Foundation Health Data for Action, Bladder Cancer Advocacy Network Young Investigator, American Urologic Association (AUA) Research Scholar and Society of Women in Urology (SWIU) Elizabeth Pickett Award. She has been recognized for her research evaluating the interplay between genetics, microbiome, and tumor microenvironment. Further, her recognition by the American Association of Cancer Research (AACR) as one of the Top Women in Cancer Research underscores her standing as a pioneering figure among women cancer surgeon scientists.
She serves as an associate editor of European Urology and a member of the editorial board for Urology Times. She also serves on the International Bladder Cancer Network committee and as an expert for kidney cancer for the Society of Immunotherapy of Cancer, underscoring her commitment to advancing research and innovation in bladder and kidney cancer.
Dr. Bukavina is committed to enhancing bladder cancer treatment by pioneering surgical innovations, such as enhancing neobladder procedures and pelvic floor reconstruction with nerve preservation. Additionally, she has extensive experience in hereditary renal cell carcinoma and renal preservation for both primary and recurrent kidney cancer.
Disclosure information not submitted.
Sunday, April 30, 2023
7:00 AM – 7:10 AM CST
Sunday, April 30, 2023
8:50 AM – 9:00 AM CST